Charoen Pokphand Enterprise (Taiwan) Co., Ltd.(1215.TW)
No price history available.
Key financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWDm | 22,190 | 24,841 | 28,959 | 29,160 | 27,957 | 28,432 | N/A | N/A |
| Operating profit | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | TWDm | 1,657 | 1,356 | 1,555 | 2,269 | 1,930 | 3,077 | N/A | N/A |
| EPS reported | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Charoen Pokphand Enterprise (Taiwan) Co., Ltd. (CPET) operates within the agriculture, animal husbandry, and meat sectors throughout Taiwan and Asia. Its activities are categorized into the Feed Business Group, Meat Processing, Food Processing, Egg Chicken, and other operational divisions. The company manufactures and distributes a wide variety of animal feed tailored for poultry (chickens, ducks), swine, and cattle, among other animals. It also creates and markets various processed chicken products. Moreover, CPET procures and supplies a comprehensive range of animal health and farm essentials. These include specific vaccines for poultry and pigs, antimicrobials, feed additives, premium raw materials for feed production, natural health agents, cleaning and disinfectant products, and diluent for artificial insemination. Beyond product sales, the company extends its services to include husbandry management for chicken farms, focusing on optimizing egg and meat yield. Additionally, it engages in the breeding of chickens and pigs and provides electric slaughtering services for poultry. Founded in 1921, the enterprise was originally named Taiwan Pokphand Feed Co., Ltd., adopting its current designation, Charoen Pokphand Enterprise (Taiwan) Co., Ltd., in 1988. Its corporate headquarters are situated in Taipei City, Taiwan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Charoen Pokphand Enterprise (Taiwan) Co., Ltd. (1215.TW)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Charoen Pokphand Enterprise (Taiwan) Co., Ltd. (CPET) operates within the agriculture, animal husbandry, and meat sectors throughout Taiwan and Asia. Its activities are categorized into the Feed Business Group, Meat Processing, Food Processing, Egg Chicken, and other operational divisions. The company manufactures and distributes a wide variety of animal feed tailored for poultry (chickens, ducks), swine, and cattle, among other animals. It also creates and markets various processed chicken products. Moreover, CPET procures and supplies a comprehensive range of animal health and farm essentials. These include specific vaccines for poultry and pigs, antimicrobials, feed additives, premium raw materials for feed production, natural health agents, cleaning and disinfectant products, and diluent for artificial insemination. Beyond product sales, the company extends its services to include husbandry management for chicken farms, focusing on optimizing egg and meat yield. Additionally, it engages in the breeding of chickens and pigs and provides electric slaughtering services for poultry. Founded in 1921, the enterprise was originally named Taiwan Pokphand Feed Co., Ltd., adopting its current designation, Charoen Pokphand Enterprise (Taiwan) Co., Ltd., in 1988. Its corporate headquarters are situated in Taipei City, Taiwan.
